More Fields

Filters

Profiles which have:

Recent Changes

Profiles with recent changes to:
Sign up to Download

1-6 of 6 results

  • nurabio.com
  • 11
By transforming recent scientific breakthroughs in axonal degeneration and neuroimmune regulation into neuroprotective medicines, we aim to offer renewed hope for those affected by serious neurological diseases... Nura Bio's team of leading..
Relevance: 13.793842
  • jiyacorp.com
  • 1
  • 1
  • 10
Jiya Acquisition Corp. is a Special Purpose Acquisition Company (SPAC) affiliated with Samsara BioCapital, whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business..
Relevance: 13.6749935
  • orsobio.com
  • 1
  • 12
OrsoBio is a clinical-stage biopharmaceutical company developing first-in-class therapies to address the underlying causes of organ dysfunction in patients with severe metabolic disorders. Our dedicated, highly skilled, and cohesive team of..
Relevance: 13.61919
  • www.neurogene.com
  • 5
  • 2
  • 13
Neurogene is focused on developing life-changing genetic medicines for patients families affected by rare, devastating neurological diseases... NEW YORK --(BUSINESS WIRE)--Feb. 29, 2024-- Neurogene Inc. (NASDAQ: NGNE) ("Neurogene" or "the Company"),..
Relevance: 13.12576
  • www.a9oncology.com
  • 2
  • 3
  • 15
We are developing a robust pipeline of radiopharmaceuticals to address targets spanning solid and hematologic malignancies... Backed by top-tier investors, our team has decades of expertise developing radiopharmaceuticals for highly targeted..
Relevance: 12.164327
  • www.samsaracap.com
  • 1
  • 1
  • 33
Samsara BioCapital was founded after years of working in the medical field and investment industry. Our goal is to help entrepreneurs turn their own ideas and visions into successful companies with fundraising and networking guidance. As a results-..
Relevance: 7.252877